Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.
about
p63 is a prostate basal cell marker and is required for prostate developmentEBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistanceProstate stem cell antigen: a cell surface marker overexpressed in prostate cancerBax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cellsU94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3.Dichotomy in the Epigenetic Mark Lysine Acetylation is Critical for the Proliferation of Prostate Cancer CellsInduction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactionsEmphasizing the role of Wnt5a protein expression to predict favorable outcome after radical prostatectomy in patients with low-grade prostate cancerAlteration of proliferation and apoptotic markers in normal and premalignant tissue associated with prostate cancerA phase I pharmacokinetic and pharmacodynamic correlative study of the antisense Bcl-2 oligonucleotide g3139, in combination with carboplatin and paclitaxel, in patients with advanced solid tumors.Role of the Bcl-2 gene family in prostate cancer progression and its implications for therapeutic intervention.An open-label, multicenter, phase I/II study of single-agent AT-101 in men with castrate-resistant prostate cancer.The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancyDysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunitiesBcl-2 as a predictive factor for biochemical recurrence after radical prostatectomy: an interim analysis.c-Jun NH2-terminal kinase-induced proteasomal degradation of c-FLIPL/S and Bcl2 sensitize prostate cancer cells to Fas- and mitochondria-mediated apoptosis by tetrandrineInteraction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer.Estrogen receptor beta in prostate cancer: brake pedal or accelerator?Epithelial mesenchymal transition (EMT) in prostate growth and tumor progressionRegulation of cell survival and death during Flavivirus infections.D-RNAi (messenger RNA-antisense DNA interference) as a novel defense system against cancer and viral infections.Antisense Bcl-2 sensitizes prostate cancer cells to radiationApoptotic cell signaling in cancer progression and therapyAngiogenin as a molecular target for the treatment of prostate cancer.Chapter One---Cancer terminator viruses and approaches for enhancing therapeutic outcomes.Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysisLoss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer.c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle.Genetic alterations in hormone-refractory recurrent prostate carcinomasA profile of enzalutamide for the treatment of advanced castration resistant prostate cancer.Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanomaBcl-2 expression in normal endometrium during the menstrual cycle.Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2.Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity.Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10.Correlation study of Bcl-2, B7-H1, EGFR, VEGF and colorectal cancer.Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancerExpression and prognostic significance of Bcl-2 in ovarian tumours
P2860
Q24290591-BDFCD46B-3C5E-4EB3-A462-0EFD177F52D4Q24646417-AE90E3C9-F5D4-4111-8FEF-2A03A80CECD3Q24673693-74229606-5287-4FBA-9252-5C6B1C377F2DQ24685483-7A8407D2-3487-4C4E-B242-3C4EF25A902CQ24811943-F6E5A970-8FE3-417F-81C2-44E0A610F1CDQ26795738-E59719AD-A5B6-4FEA-A738-18EF75E21308Q28343497-D32250B4-AA64-4B04-BD74-37D4C581EED8Q28709995-50579CB0-36D8-4F38-BD6D-771006814F4AQ33236893-30EAA00A-FE39-4338-875D-D95D89A54AFEQ33379466-49D1C4E9-CBD7-40E6-993B-616985A71C74Q33608788-5C664BB3-2C9B-4DFC-AFD5-E4087A185C11Q34066960-F720F21E-6A17-4DA4-A9A6-FE761B785C40Q34092523-0EF9B1FD-77E9-4DF9-A6C8-18CA9A32583DQ34139691-90BA24CD-6371-4511-9591-ADC300F144D8Q34193061-A0B23FB8-3FFD-4038-8B5F-F612FF02EC62Q34225131-83E11893-7AF3-4116-AC97-7025AB976815Q34252079-03A4F7B2-CD93-4509-A201-8DE67E79157FQ34299700-9BDC7565-259E-4B87-8DE2-D60BE774E871Q34397291-FCE6B106-E784-4901-A0BF-84400DFD01E3Q34424352-C909F883-6CE0-4069-A4BB-2CB3CD0C59E5Q34790475-E0FFC3E6-BC71-4B98-B13C-07A839CA361CQ35062101-A36A3252-8CEF-4BB3-AEF3-02614F5A9BBDQ35088734-64AA8A9F-10C3-4733-92D0-84F30522A2E8Q35090356-106ECB41-B758-421D-846F-3E7A80E7E203Q35142325-8417AEA1-6FB9-43AF-B3E8-0B7A84785895Q35167933-F4ECF58F-1860-4DD9-A0C4-55B8534F30E3Q35352194-61482BC0-0929-4581-AA6F-E2B2FD5702F2Q35538874-CB1099B9-F697-4B5D-87A9-8AAE21F14E6CQ35753171-7690AAD0-8CD0-4650-92D7-7467E0D7C349Q35754996-794A12C7-A649-4745-9FCB-57D0D7262347Q35773657-E3DEC876-7E37-4D10-9315-CD593EDCA14CQ35798545-234F55D9-7C1A-4510-9004-3CD9EBC537F9Q35834144-7DB1300C-5126-4983-9E7D-B83C8E4EDA96Q35834262-F93E8571-4EBB-4359-A232-79E7A8A5DF21Q35839316-02351722-2473-4D26-A13E-E4B9860C7300Q35873154-D0AE2864-6DC2-48B7-8474-685F1C45E9F8Q35946094-E1FBCAD4-765E-4167-9443-59B75CC8C005Q35993161-EB766BBC-A138-48F2-BFB8-DE6F1EAEB097Q36080901-D0AD2B2E-48B9-4F7D-8EB4-40528E894360Q36081344-D26D58A4-4D1E-4FC0-9333-C7DDB3C42FA4
P2860
Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Detection of the apoptosis-sup ...... actory human prostate cancers.
@ast
Detection of the apoptosis-sup ...... actory human prostate cancers.
@en
type
label
Detection of the apoptosis-sup ...... actory human prostate cancers.
@ast
Detection of the apoptosis-sup ...... actory human prostate cancers.
@en
prefLabel
Detection of the apoptosis-sup ...... actory human prostate cancers.
@ast
Detection of the apoptosis-sup ...... actory human prostate cancers.
@en
P2093
P2860
P1476
Detection of the apoptosis-sup ...... ractory human prostate cancers
@en
P2093
C A Olsson
K M O'Toole
S Korsmeyer
P2860
P304
P407
P577
1993-08-01T00:00:00Z